Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data

Guy W Glover, Richard M Thomas, George Vamvakas, Nawaf Al-Subaie, Jules Cranshaw, Andrew Walden, Matthew P Wise, Marlies Ostermann, Emma Thomas-Jones, Tobias Cronberg, David Erlinge, Yvan Gasche, Christian Hassager, Janneke Horn, Jesper Kjaergaard, Michael Kuiper, Tommaso Pellis, Pascal Stammet, Michael Wanscher, Jørn Wetterslev, Hans Friberg, Niklas Nielsen, Guy W Glover, Richard M Thomas, George Vamvakas, Nawaf Al-Subaie, Jules Cranshaw, Andrew Walden, Matthew P Wise, Marlies Ostermann, Emma Thomas-Jones, Tobias Cronberg, David Erlinge, Yvan Gasche, Christian Hassager, Janneke Horn, Jesper Kjaergaard, Michael Kuiper, Tommaso Pellis, Pascal Stammet, Michael Wanscher, Jørn Wetterslev, Hans Friberg, Niklas Nielsen

Abstract

Background: Targeted temperature management is recommended after out-of-hospital cardiac arrest and may be achieved using a variety of cooling devices. This study was conducted to explore the performance and outcomes for intravascular versus surface devices for targeted temperature management after out-of-hospital cardiac arrest.

Method: A retrospective analysis of data from the Targeted Temperature Management trial. N = 934. A total of 240 patients (26%) managed with intravascular versus 694 (74%) with surface devices. Devices were assessed for speed and precision during the induction, maintenance and rewarming phases in addition to adverse events. All-cause mortality, as well as a composite of poor neurological function or death, as evaluated by the Cerebral Performance Category and modified Rankin scale were analysed.

Results: For patients managed at 33 °C there was no difference between intravascular and surface groups in the median time taken to achieve target temperature (210 [interquartile range (IQR) 180] minutes vs. 240 [IQR 180] minutes, p = 0.58), maximum rate of cooling (1.0 [0.7] vs. 1.0 [0.9] °C/hr, p = 0.44), the number of patients who reached target temperature (within 4 hours (65% vs. 60%, p = 0.30); or ever (100% vs. 97%, p = 0.47), or episodes of overcooling (8% vs. 34%, p = 0.15). In the maintenance phase, cumulative temperature deviation (median 3.2 [IQR 5.0] °C hr vs. 9.3 [IQR 8.0] °C hr, p = <0.001), number of patients ever out of range (57.0% vs. 91.5%, p = 0.006) and median time out of range (1 [IQR 4.0] hours vs. 8.0 [IQR 9.0] hours, p = <0.001) were all significantly greater in the surface group although there was no difference in the occurrence of pyrexia. Adverse events were not different between intravascular and surface groups. There was no statistically significant difference in mortality (intravascular 46.3% vs. surface 50.0%; p = 0.32), Cerebral Performance Category scale 3-5 (49.0% vs. 54.3%; p = 0.18) or modified Rankin scale 4-6 (49.0% vs. 53.0%; p = 0.48).

Conclusions: Intravascular and surface cooling was equally effective during induction of mild hypothermia. However, surface cooling was associated with less precision during the maintenance phase. There was no difference in adverse events, mortality or poor neurological outcomes between patients treated with intravascular and surface cooling devices.

Trial registration: TTM trial ClinicalTrials.gov number https://ichgcp.net/clinical-trials-registry/NCT01020916 NCT01020916; 25 November 2009.

Keywords: Brain injuries; Critical care; Fever; Hypothermia; Induced; Out-of-hospital cardiac arrest; Shivering; Temperature.

Figures

Fig. 1
Fig. 1
Patient temperature for the 33 °C group over the intervention periods. Mean and standard deviation temperature (°C). Blue line and shading is intravascular group, red line and shading is surface group. Time in hours
Fig. 2
Fig. 2
Patient temperature for the 36 °C group over the intervention periods. Mean and standard deviation temperature (°C). Blue line and shading is intravascular group, red line and shading is surface group. Time in hours
Fig. 3
Fig. 3
Performance of surface versus intravascular devices in induction phase. Effect estimates and 95% confidence intervals. SFC surface device, IV intravascular
Fig. 4
Fig. 4
Performance of surface versus intravascular devices in maintenance phase. Effect estimates and 95% confidence intervals. SFC surface device, IV intravascular
Fig. 5
Fig. 5
Adverse events for surface versus intravascular devices. Effect estimates and 95% confidence intervals. SFC surface device, IV intravascular

References

    1. Arrich J, Holzer M, Havel C, Müllner M, Herkner H. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2012, Issue 9. Art. No.: CD004128. doi:10.1002/14651858.CD004128.pub3
    1. Poldermann KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37:S186–S202. doi: 10.1097/CCM.0b013e3181aa5241.
    1. Bernard SA, Smith K, Cameron P, et al. Rapid Infusion of Cold Hartmanns (RICH) Investigators: induction of prehospital therapeutic hypothermia after resuscitation from nonventricular fibrillation cardiac arrest. Crit Care Med. 2012;40:747–753. doi: 10.1097/CCM.0b013e3182377038.
    1. Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37:1101–1120. doi: 10.1097/CCM.0b013e3181962ad5.
    1. Uray T, Sterz F, Janata A, et al. Surface cooling with a new cooling-blanket for rapid induction of mild hypothermia in humans after cardiac arrest: a feasibility trial. Resuscitation. 2006;69:93.
    1. Al-Senani FM, Graffagnino C, Grotta JC, Saiki R, Wood D, Chung W, Palmer G, Collins KA. A prospective, multicenter pilot study to evaluate the feasibility and safety of using the CoolGuard System and Icy catheter following cardiac arrest. Resuscitation. 2004;62:143–150. doi: 10.1016/j.resuscitation.2004.02.016.
    1. Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med. 2002;30:2481–2488. doi: 10.1097/00003246-200211000-00013.
    1. Polderman KH, Callaghan J. Equipment review: Cooling catheters to induce therapeutic hypothermia? Crit Care. 2006;10:234. doi: 10.1186/cc5023.
    1. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med. 2006;34:1865–1873. doi: 10.1097/01.CCM.0000221922.08878.49.
    1. Laish-Farkash A, Matetzky S, Kassem S, Haj-Iahia H, Hod H. Therapeutic hypothermia for comatose survivors after cardiac arrest. Israel Med Assoc J. 2007;9:252–256.
    1. Heard K, Peberdy M, Sayre M, et al. A randomized controlled trial comparing the arctic sun to standard cooling for induction of hypothermia after cardiac arrest. Resuscitation. 2010;81:9–14. doi: 10.1016/j.resuscitation.2009.09.015.
    1. Haugk M, Sterz F, Grassberger M, et al. Feasibility and efficacy of a new non-invasive surface cooling device in post-resuscitation intensive care medicine. Resuscitation. 2007;75:76–81. doi: 10.1016/j.resuscitation.2007.03.001.
    1. Seder DB, Van der Kloot TE. Methods of cooling: practical aspects of therapeutic temperature management. Crit Care Med. 2009;37:S211–S222. doi: 10.1097/CCM.0b013e3181aa5bad.
    1. Storm C. In-hospital hypothermia. Crit Care. 2012;16(Suppl 2):A5. doi: 10.1186/cc11263.
    1. Holzer M. Devices for rapid induction of hypothermia. Eur J Anaesthesiol. 2008;25:31–38. doi: 10.1017/S0265021507003274.
    1. Shinada T, Hata N, Yokoyama S, Kobayashi N, Tomita K, Shirakabe A, et al. Usefulness of a surface cooling device (Arctic Sun®) for therapeutic hypothermia following cardiac arrest. J Cardiol. 2014;63:46–52. doi: 10.1016/j.jjcc.2013.06.013.
    1. Merchant RM, Abella BS, Peberdy MA, et al. Therapeutic hypothermia after cardiac arrest: unintentional overcooling is common using ice packs and conventional cooling blankets. Crit Care Med. 2006;12:S490–S494. doi: 10.1097/01.CCM.0000246016.28679.36.
    1. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. Acta Anaesthesiol Scand. 2006;50:1277–1283. doi: 10.1111/j.1399-6576.2006.01147.x.
    1. Hoedemaekers C, Ezzahti M, Gerritsen A, van der Hoeven J. Comparison of cooling methods to induce and maintain normo- and hypothermia in intensive care unit patients: a prospective intervention study. Crit Care. 2007;11:R91. doi: 10.1186/cc6104.
    1. Gillies MA, Pratt R, Whiteley C, Borg J, Beale RJ, Tibby SM. Therapeutic hypothermia after cardiac arrest: a retrospective comparison of surface and endovascular cooling techniques. Resuscitation. 2010;81:1117–1122. doi: 10.1016/j.resuscitation.2010.05.001.
    1. Keller E, Imhof HG, Gasser S, et al. Endovascular cooling with heat exchange catheters: A new method to induce and maintain hypothermia. Intensive Care Med. 2003;29:939–943. doi: 10.1007/s00134-003-1685-3.
    1. Diringer MN, Group NCFRT. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32:559–564. doi: 10.1097/01.CCM.0000108868.97433.3F.
    1. Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004;32:2508–2515. doi: 10.1097/01.CCM.0000147441.39670.37.
    1. Tømte Ø, Drægni T, Mangschau A, Jacobsen D, Auestad B, Sunde K. A comparison of intravascular and surface cooling techniques in comatose cardiac arrest survivors. Crit Care Med. 2011;39:443–449. doi: 10.1097/CCM.0b013e318206b80f.
    1. Oh SH, Oh JS, Kim Y, et al. An observational study of surface versus endovascular cooling techniques in cardiac arrest patients: a propensity-matched analysis. Crit Care. 2015;19:85–97. doi: 10.1186/s13054-015-0819-7.
    1. Pittl U, Schratter A, Desch S, Diosteanu R, Lehmann D, Demmin K, et al. Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial. Clin Res Cardiol. 2013;102:607–614. doi: 10.1007/s00392-013-0572-3.
    1. Deye N, Cariou A, Girardie P, et al. Endovascular versus external targeted temperature management for patients with out-of-hospital cardiac arrest. A randomized, controlled study. Circulation. 2015;132:182–19. doi: 10.1161/CIRCULATIONAHA.114.012805.
    1. Lindenblatt N, Menger MD, Klar E, et al. Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol Heart Circ Physiol. 2005;289:2680–2687. doi: 10.1152/ajpheart.00425.2005.
    1. Erlinge D, Götberg M, Noc M, et al. Therapeutic hypothermia for the treatment of acute myocardial infarction – combined analysis of the RAPID MI-ICE and the CHILL-MI trials. Ther Hypothermia Temp Manag. 2015;5:77–84. doi: 10.1089/ther.2015.0009.
    1. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 °C versus 36 °C after cardiac arrest. N Engl J Med. 2013;369:2197–2206. doi: 10.1056/NEJMoa1310519.
    1. Deakin CD, Morrison LJ, Morley PT, et al. Advanced Life Support Chapter Collaborators. Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation. 2010;81(Suppl 1):e93–e174. doi: 10.1016/j.resuscitation.2010.08.027.
    1. Nielson N for the TTM investigators Target temperature management after out-of-hospital cardiac arrest - a randomized, parallel-group, assessor-blinded clinical trial - rationale and design. Am Heart J. 2012;163:541–548. doi: 10.1016/j.ahj.2012.01.013.
    1. Polderman KH. Keeping a cool head: how to induce and maintain hypothermia. Crit Care Med. 2004;32:2558–2560. doi: 10.1097/01.CCM.0000148087.41418.0A.
    1. Holzer M, Müllner M, Sterz F, et al. Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach. Stroke. 2006;37:1792–1797. doi: 10.1161/01.STR.0000227265.52763.16.
    1. Arrich J. The European Resuscitation Council Hypothermia After Cardiac Arrest Registry Study Group. Clinical application of mild therapeutic hypothermia after cardiac arrest. Crit Care Med. 2007;35:1041–1047. doi: 10.1097/01.CCM.0000259383.48324.35.
    1. Kliegel A, Losert H, Sterz F, et al. Cold simple intravenous infusions preceding special endovascular cooling for faster induction of mild hypothermia after cardiac arrest – a feasibility study. Resuscitation. 2005;64:347–351. doi: 10.1016/j.resuscitation.2004.09.002.
    1. Kim F, Nichol G, Maynard C, et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest. A randomized clinical trial. JAMA. 2014;311:45–52. doi: 10.1001/jama.2013.282173.
    1. Pichon N, Amiel JB, Francois B, et al. Efficacy of and tolerance of mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system. Crit Care. 2007;11:R71. doi: 10.1186/cc5956.
    1. The Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549–556. doi: 10.1056/NEJMoa012689.
    1. Kilgannon JH, Roberts BW, Stauss M, et al. Use of a standardized order set for achieving target temperature in the implementation of therapeutic hypothermia after cardiac arrest: a feasibility study. Acad Emerg Med. 2008;15:499–505. doi: 10.1111/j.1553-2712.2008.00102.x.
    1. Belliard G, Catez E, Charron C, et al. Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation. 2007;75:252–259. doi: 10.1016/j.resuscitation.2007.04.014.
    1. Wang HE, Wells JM, Rizk DV. Bullous lesions after use of a commercial therapeutic hypothermia temperature management system: a possible burn injury? Ther Hypothermia Temp Manag. 2013;3:147–150. doi: 10.1089/ther.2013.0013.
    1. Varona J, Acostac P, Wintzd R, Mendoza N. Unusual side effect from hydrogel pads during therapeutic hypothermia. Resuscitation. 2008;78:248–249. doi: 10.1016/j.resuscitation.2008.03.223.
    1. Simosa HF, Petersen DJ, Agarwal SK, et al. Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. Am Surg. 2007;73:461–464.
    1. Prunet B, Lacroix G, Bordes J, Poyet R, D’Aranda E, Goutorbe P. Catheter related venous thrombosis with cooling and warming catheters: two case reports. Cases J. 2009;2:8857. doi: 10.4076/1757-1626-2-8857.
    1. Doufas AG, Akca O, Barry A, Petrusca DA, Suleman MI, Morioka N, Guarnaschelli JJ, Sessler DI. Initial experience with a novel heat-exchanging catheter in neurosurgical patients. Anesth Analg. 2002;95:1752–1756. doi: 10.1097/00000539-200212000-00052.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel